Omega-3 on Lipid Profile & Serum Leptin Level n Neonates With Intrauterine

Status Completed

Clinical Trial Summary

The aim of our study will demonstrate the effect of omega 3 supplementation on serum lipid profile level and leptin level in neonates with Intrauterine Growth Restriction( IUGR)

Clinical Trial Description

Intrauterine growth restriction is a major cause of perinatal mortality and morbidity . It is noted to affect approximately 5-15 % of pregnant women. Egypt has one of the highest incidences of Intrauterine Growth Restriction. The incidence of IUGR varies among countries, populations, races and increases with decreasing gestational age. 14 to 20 million infants have been affected with Intrauterine Growth Restriction cases in the developing countries annually. A complex and dynamic interaction of maternal, placental and fetal environment is involved in ensuring normal fetal growth. An imbalance or lack of coordination in this complex system may lead to Intrauterine Growth Restriction. Intrauterine Growth Restriction( IUGR) results in significant perinatal and long-term complications, including increased neonatal mortality and morbidity and higher risk for developing metabolic syndrome later in life. Physiological differences have been noted in growth restricted infants. Intrauterine amino acid disturbances similar to biochemical changes seen in postnatal protein deprived states have been detected. Protein metabolism defect and altered lipid metabolism also have been described. Undernourishment in utero appears to be associated with persisting changes in the metabolic functions. Birth weight influences the lipoprotein profile and cholesteryl ester transfer protein, which promotes a proatherogenic lipoprotein profile in plasma by determining chemical, physical and biological properties of the respective lipoprotein particle in neonates. Recent research suggests that several of major disease of later life, including coronary heart disease, hypertension & type II diabetes originate in impaired intrauterine growth and development. These diseases may be consequence of programming whereby a stimulus or insult at a critical, sensitive period of early life has a permanent effect on structure, physiology and metabolism. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05242107
Study type	Interventional
Source	Tanta University
Contact
Status	Completed
Phase	N/A
Start date	June 1, 2021
Completion date	January 10, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04506970` - Predicting Placental Pathologies by Ultrasound Imaging
Recruiting	`NCT03866863` - Intra Uterine Growth Restriction
Recruiting	`NCT03662178` - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Not yet recruiting	`NCT05720169` - Fetal, Obstetrics and Reproduction Genomics
Completed	`NCT04633551` - Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes	N/A
Recruiting	`NCT05500989` - PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
Recruiting	`NCT04141189` - Comparison of Follow-up Protocols in Terms of Fetal, Neonatal and Maternal Results in Intrauterine Growth Retardation	N/A
Completed	`NCT03726697` - Effect of Tahneek on Hypoglycemia in Newborn Infants	N/A
Not yet recruiting	`NCT06226051` - Growing Little PEAPODS Study
Recruiting	`NCT03398629` - Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies
Recruiting	`NCT02473991` - Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight	N/A
Completed	`NCT02696577` - The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction	Phase 2
Recruiting	`NCT04766866` - sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.	N/A
Terminated	`NCT04047966` - Study of the Fetal and Maternal Microbiota in Preganant Women With Fetal Defect Growth
Not yet recruiting	`NCT03865628` - Ultrasound Evaluation of Fetal Hemodynamics and Perinatal Complications
Completed	`NCT05328453` - Sonographic 3D Measurement of Fetal Thymus May be Used to Predict the Small Baby in Pregnancy.
Completed	`NCT05800938` - The Effect of Oral Isosorbide Mononitrate Therapy on Umbilical Artery Doppler Resistance Index in Pregnancies With Intrauterine Growth Restriction: Prospective Randomized Control Trial	Phase 4
Recruiting	`NCT02807324` - Women Specific Cardiac Recovery After Preeclampsia
Recruiting	`NCT02515292` - Evaluation of Infants With Intrauterine Growth Restriction	N/A
Active, not recruiting	`NCT01942525` - Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Omega-3 on Lipid Profile and Serum Leptin Level n Neonates With Intrauterine Growth Restriction

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms